Renovascular Disease and Mitochondrial Dysfunction in Human Mesenchymal Stem Cells

Author:

Eirin Alfonso12ORCID,Siddiqi Sarosh1ORCID,Hughes Autumn G.1ORCID,Jiang Yamei1ORCID,Zhu Xiang-Yang1ORCID,Kazeminia Sara1ORCID,Lu Bo1,Xing Li1ORCID,Lu Brandon1ORCID,Tang Hui1,Xue Ailing1,Lerman Amir2ORCID,Textor Stephen C.1,Lerman Lilach O.12ORCID

Affiliation:

1. Division of Nephrology and Hypertension, Department of Medicine, Mayo Clinic, Rochester, Minnesota

2. Department of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota

Abstract

Key Points Renovascular disease impairs the capacity of human adipose tissue–derived mesenchymal stem/stromal cells to repair ischemic murine kidneys.miR-378h modulated the capacity of renovascular disease adipose tissue–derived mesenchymal stem/stromal cells to repair ischemic kidneys in vivo. Background Renovascular disease leads to renal ischemia, hypertension, and eventual kidney failure. Autologous transplantation of adipose tissue–derived mesenchymal stem/stromal cells (MSCs) improves perfusion and oxygenation in stenotic human kidneys, but associated atherosclerosis and hypertension might blunt their effectiveness. We hypothesized that renovascular disease alters the human MSC transcriptome and impairs their reparative potency. Methods MSCs were harvested from subcutaneous abdominal fat of patients with renovascular disease and healthy volunteers (n=3 each), characterized and subsequently injected (5×105/200 μl) into mice 2 weeks after renal artery stenosis or sham surgery (n=6/group). Two weeks later, mice underwent imaging and tissue studies. MSCs from healthy volunteers and in those with renovascular disease were also characterized by mRNA/microRNA (miRNA) sequencing. Based on these, MSC proliferation and mitochondrial damage were assessed in vitro before and after miRNA modulation and in vivo in additional renal artery stenosis mice administered with MSCs from renovascular disease pretreated with miR-378h mimic (n=5) or inhibitor (n=4). Results MSCs engrafted in stenotic mouse kidneys. Healthy volunteer MSCs (but not renovascular disease MSCs) decreased BP, improved serum creatinine levels and stenotic-kidney cortical perfusion and oxygenation, and attenuated peritubular capillary loss, tubular injury, and fibrosis. Genes upregulated in renovascular disease MSCs versus healthy volunteer MSCs were mostly implicated in transcription and cell proliferation, whereas those downregulated encoded mainly mitochondrial proteins. Upregulated miRNAs, including miR-378h, primarily target nuclear-encoded mitochondrial genes, whereas downregulated miRNAs mainly target genes implicated in transcription and cell proliferation. MSC proliferation was similar, but their mitochondrial structure and reparative function both in vivo and in vitro improved after miR-378h inhibition. Conclusions Renovascular disease impaired the reparative capacity of human MSCs, possibly by dysregulating miR-378h that targets mitochondrial genes.

Funder

NHLBI Division of Intramural Research

National Institute of Diabetes and Digestive and Kidney Diseases

National Institute on Aging

Regenerative Medicine Minnesota

Publisher

Ovid Technologies (Wolters Kluwer Health)

Reference71 articles.

1. Renal arterial disease and hypertension;Textor;Med Clin North Am.,2017

2. Darkness at the end of the tunnel: poststenotic kidney injury;Eirin;Physiology (Bethesda).,2013

3. Prevalence of renovascular disease in the elderly: a population-based study;Hansen;J Vasc Surg.,2002

4. Severity of renal vascular disease predicts mortality in patients undergoing coronary angiography;Conlon;Kidney Int.,2001

5. Stenting and medical therapy for atherosclerotic renal-artery stenosis;Cooper;N Engl J Med.,2014

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3